Globenewswire

Investment to accelerate Workplace Options’ strategy of rapid growth and innovation.

- Discovery efforts will focus on small molecules with differentiated clinical profiles to harness the broad potential of orexin agonism across different indications,
- First time Schrödinger is applying its computational platform in an orexin agonist setting enabled by Orexia’s structural biology capabilities.

New Solution Serves as the Intelligence Command Center for Life Sciences Commercial and Medical Teams.

New Engine Integrates All Sources of Insight and Uses Transparent AI to Overcome Barriers to Scale.